Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
YES1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
RPL24 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CAV2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PPA1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BUB3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PARPBP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TM9SF3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EIF2AK2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GPR19 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IFI16 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ANKRD28 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SGMS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TFAM - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SARNP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PRDM1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMED5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EAF2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
OAT - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
USMG5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TROVE2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on